Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT).

Literature DB >> 23269951

Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT).

Ammad Al-Tamimi¹, Sumbul Zaheer, Chow Kah Hoe Pierce, Saabry Osmany, Kesavan Sittampalam.

Abstract

Entities: Disease

Year: 2012 PMID： 23269951 PMCID： PMC3529665

Source DB: PubMed Journal: Sultan Qaboos Univ Med J ISSN： 2075-051X

× No keyword cloud information.

10 in total

Review 1. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

Authors: K Mizutani; Y Tamada; K Hara; T Tsuzuki; H Saeki; K Tamaki; Y Matsumoto
Journal: Br J Dermatol Date: 2004-07 Impact factor: 9.302

2. Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: a case report.

Authors: Olivier Cottier; Maryse Fiche; Jean-Yves Meuwly; Jean-François Delaloye
Journal: J Med Case Rep Date: 2011-10-05

3. Recurrence of dermatofibrosarcoma protuberans in post-surgical scar detected by 18F-FDG-PET imaging.

Authors: Sandip Basu; Nawab Singh Baghel
Journal: Hell J Nucl Med Date: 2009 Jan-Apr Impact factor: 1.102

4. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

Authors: Brian P Rubin; Scott M Schuetze; Janet F Eary; Thomas H Norwood; Sohail Mirza; Ernest U Conrad; James D Bruckner
Journal: J Clin Oncol Date: 2002-09-01 Impact factor: 44.544

2 in total

1. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in dermatofibrosarcoma protuberans on treatment with imatinib.

Authors: Raghava Kashyap; Vamshi Krishna Muddu; Sameera Anantamakula; Satya Sri
Journal: Indian J Nucl Med Date: 2016 Jul-Sep

2. Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT.

Authors: Suk Hyun Bae; Ji Young Lee
Journal: Iran J Radiol Date: 2016-02-23 Impact factor: 0.212

2 in total

Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT).

Review 1. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

2. Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: a case report.

3. Recurrence of dermatofibrosarcoma protuberans in post-surgical scar detected by 18F-FDG-PET imaging.

4. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

5. Late local recurrence of dermatofibrosarcoma protuberans in the skin of female breast.

6. Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Review 7. Dermatofibrosarcoma protuberans: recent clinical progress.

8. Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

9. Imatinib in the treatment of dermatofibrosarcoma protuberans.

Review 10. Dermatofibrosarcoma protuberans treated by micrographic surgery.

1. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in dermatofibrosarcoma protuberans on treatment with imatinib.

2. Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT.